Majem, M; Sullivan, I; Viteri, S; Lopez-Vivanco, G; Cobo, M; Sanchez, JM; Garcia-Gonzalez, J; Garde, J; Sampayo, M; Martrat, G; Malfettone, A; Karachaliou, N; Molina-Vila, MA; Rosell, R – 2021
First-line osimertinib in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met
by prodriguez | Jan 1, 2021 | Publicaciones - CIMO-02 | 0 comments